Less is more? STI in acute and chronic HIV-1 infection

被引：40

作者：

Altfeld, M ^{[1
]}

Walker, BD

机构：

[1] Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

来源：

NATURE MEDICINE | 2001年 / 7卷 / 08期

关键词：

D O I：

10.1038/90901

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Emerging data has indicated that supervised treatment interruption (STI) of highly active antiretroviral therapy might significantly augment immune responses in HIV-1-infected patients and slow disease progression. Here the authors discuss the rationale behind STI and future directions for study.

引用

页码：881 / 884

页数：4

共 54 条

[31] Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men [J].

Lyles, RH ;

Muñoz, A ;

Yamashita, TE ;

Bazmi, H ;

Detels, R ;

Rinaldo, CR ;

Margolick, JB ;

Phair, JP ;

Mellors, JW .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (03) :872-880

[32] Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection [J].

Malhotra, U ;

Berrey, MM ;

Huang, YJ ;

Markee, J ;

Brown, DJ ;

Ap, S ;

Musey, L ;

Schacker, T ;

Corey, L ;

McElrath, MJ .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) :121-131

[33]

MARKOWITZ M, 2001, 8 C RETR OPP INF CHI

[34] Cellular immune responses to HIV [J].

McMichael, AJ ;

Rowland-Jones, SL .

NATURE, 2001, 410 (6831) :980-987

[35] HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors [J].

Migueles, SA ;

Sabbaghian, MS ;

Shupert, WL ;

Bettinotti, MP ;

Marincola, FM ;

Martino, L ;

Hallahan, CW ;

Selig, SM ;

Schwartz, D ;

Sullivan, J ;

Connors, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2709-2714

[36] Structured treatment interruptions in antiretroviral management of HIV-1 [J].

Miller, V .

CURRENT OPINION IN INFECTIOUS DISEASES, 2001, 14 (01) :29-37

[37] Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure [J].

Miller, V ;

Sabin, C ;

Hertogs, K ;

Bloor, S ;

Martinez-Picado, J ;

D'Aquila, R ;

Larder, B ;

Lutz, T ;

Gute, P ;

Weidmann, E ;

Rabenau, H ;

Phillips, A ;

Staszewski, S .

AIDS, 2000, 14 (18) :2857-2867

[38] Structured treatment interruptions to control HIV-1 and limit drug exposure [J].

Montaner, LJ .

TRENDS IN IMMUNOLOGY, 2001, 22 (02) :92-96

[39] HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment [J].

Neumann, AU ;

Tubiana, R ;

Calvez, V ;

Robert, C ;

Li, TS ;

Agut, H ;

Autran, B ;

Katlama, C .

AIDS, 1999, 13 (06) :677-683

[40] Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA [J].

Ogg, GS ;

Jin, X ;

Bonhoeffer, S ;

Dunbar, PR ;

Nowak, MA ;

Monard, S ;

Segal, JP ;

Cao, YZ ;

Rowland-Jones, SL ;

Cerundolo, V ;

Hurley, A ;

Markowitz, M ;

Ho, DD ;

Nixon, DF ;

McMichael, AJ .

SCIENCE, 1998, 279 (5359) :2103-2106

← 1 2 3 4 5 6 →